Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Carter PH, Hynes J. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338. Expert Opin Ther Pat 2010;20:1609-18. [DOI: 10.1517/13543776.2010.518144] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]

For:	Carter PH, Hynes J. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338. Expert Opin Ther Pat 2010;20:1609-18. [DOI: 10.1517/13543776.2010.518144] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]

Number

Cited by Other Article(s)

Harcken C, Kuzmich D, Cook B, Mao C, Disalvo D, Razavi H, Swinamer A, Liu P, Zhang Q, Kukulka A, Skow D, Patel M, Patel M, Fletcher K, Sherry T, Joseph D, Smith D, Canfield M, Souza D, Bogdanffy M, Berg K, Brown M. Identification of novel azaindazole CCR1 antagonist clinical candidates. Bioorg Med Chem Lett 2019;29:441-448. [PMID: 30595446 DOI: 10.1016/j.bmcl.2018.12.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 12/08/2018] [Accepted: 12/12/2018] [Indexed: 11/27/2022]

Affiliation(s)

Christian Harcken Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA.
Daniel Kuzmich Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Brain Cook Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Can Mao Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Darren Disalvo Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Hossein Razavi Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Alan Swinamer Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Pingrong Liu Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Qiang Zhang Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Alison Kukulka Compound Profiling Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Donna Skow Compound Profiling Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Mita Patel Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Monica Patel Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Kimberly Fletcher Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Tara Sherry Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
David Joseph Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Dustin Smith Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Melissa Canfield Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Donald Souza Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Matthew Bogdanffy Non-Clinical Drug Safety Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Karen Berg Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Maryanne Brown Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA

Collapse

Harcken C, Sarko C, Mao C, Lord J, Raudenbush B, Razavi H, Liu P, Swinamer A, Disalvo D, Lee T, Lin S, Kukulka A, Grbic H, Patel M, Patel M, Fletcher K, Joseph D, White D, Amodeo L, Berg K, Brown M, Thomson DS. Discovery and optimization of pyrazole amides as antagonists of CCR1. Bioorg Med Chem Lett 2019;29:435-440. [PMID: 30455146 DOI: 10.1016/j.bmcl.2018.11.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 11/04/2018] [Accepted: 11/08/2018] [Indexed: 11/25/2022]

Affiliation(s)

Christian Harcken Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA.
Christopher Sarko Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Can Mao Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
John Lord Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Brian Raudenbush Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Hossein Razavi Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Pingrong Liu Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Alan Swinamer Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Darren Disalvo Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Thomas Lee Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Siqi Lin Compound Profiling Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Alison Kukulka Compound Profiling Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Heather Grbic Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Mita Patel Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Monica Patel Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Kim Fletcher Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
David Joseph Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Della White Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Laura Amodeo Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Karen Berg Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
Maryanne Brown Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
David S Thomson Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA

Collapse

Santella JB, Gardner DS, Duncia JV, Wu H, Dhar M, Cavallaro C, Tebben AJ, Carter PH, Barrish JC, Yarde M, Briceno SW, Cvijic ME, Grafstrom RR, Liu R, Patel SR, Watson AJ, Yang G, Rose AV, Vickery RD, Caceres-Cortes J, Caporuscio C, Camac DM, Khan JA, An Y, Foster WR, Davies P, Hynes J. Discovery of the CCR1 Antagonist, BMS-817399, for the Treatment of Rheumatoid Arthritis. J Med Chem 2014;57:7550-64. [DOI: 10.1021/jm5003167] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]

Affiliation(s)

Joseph B. Santella Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Daniel S. Gardner Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
John V. Duncia Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Hong Wu Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Murali Dhar Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Cullen Cavallaro Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Andrew J. Tebben Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Percy H. Carter Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Joel C. Barrish Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Melissa Yarde Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Stephanie W. Briceno Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Mary Ellen Cvijic Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
R. Robert Grafstrom Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Richard Liu Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Sima R. Patel Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Andrew J. Watson Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Guchen Yang Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Anne V. Rose Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Rodney D. Vickery Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Janet Caceres-Cortes Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Christian Caporuscio Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Daniel M. Camac Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Javed A. Khan Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Yongmi An Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
William R. Foster Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Paul Davies Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
John Hynes Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States

Collapse

Chukwu JU, López C, González A, Font-Bardía M, Calvet MT, Messeguer R, Calvis C. Pd(II) complexes with N-substituted pyrazoles as ligands. The influence of the R group [OMe versus NMe2] of [1-{R–(CH2)2–}-3,5-Ph2–(C3HN2)] on their cytotoxic activity on breast cancer cell lines. J Organomet Chem 2014. [DOI: 10.1016/j.jorganchem.2014.04.034] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]

Gardner DS, Santella JB, Duncia JV, Carter PH, Dhar T, Wu H, Guo W, Cavallaro C, Van Kirk K, Yarde M, Briceno SW, Robert Grafstrom R, Liu R, Patel SR, Tebben AJ, Camac D, Khan J, Watson A, Yang G, Rose A, Foster WR, Cvijic ME, Davies P, Hynes J. The discovery of BMS-457, a potent and selective CCR1 antagonist. Bioorg Med Chem Lett 2013;23:3833-40. [DOI: 10.1016/j.bmcl.2013.04.079] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2013] [Revised: 04/24/2013] [Accepted: 04/29/2013] [Indexed: 02/07/2023]

Cavallaro CL, Briceno S, Chen J, Cvijic ME, Davies P, Hynes J, Liu RQ, Mandlekar S, Rose AV, Tebben AJ, Van Kirk K, Watson A, Wu H, Yang G, Carter PH. Discovery and Lead Optimization of a Novel Series of CC Chemokine Receptor 1 (CCR1)-Selective Piperidine Antagonists via Parallel Synthesis. J Med Chem 2012;55:9643-53. [DOI: 10.1021/jm300896d] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]

Affiliation(s)

Cullen L. Cavallaro Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Stephanie Briceno Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Jing Chen Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Mary Ellen Cvijic Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Paul Davies Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
John Hynes Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Rui-Qin Liu Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Sandhya Mandlekar Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Anne V. Rose Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Andrew J. Tebben Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Katy Van Kirk Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Andrew Watson Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Hong Wu Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Guchen Yang Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Percy H. Carter Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States

Collapse